boucenna amira, Hirech A, Larbi RM, Satta D. Impact of CYP2D6 Polymorphisms in Predicting Occurrence of Adverse Effect to Tamoxifen and Developing Recurrence in ER+ Breast Cancer Patients. Arch Breast Cancer [Internet]. 2024 Oct. 25 [cited 2024 Oct. 31];11(4). Available from: https://archbreastcancer.com/index.php/abc/article/view/988